Four Takeaways From the Metropolitan Opera’s Risky Season

For years, the Metropolitan Opera — the nation’s largest performing arts institution, with a $300 million budget and 4,000-seat theater — was like an ocean liner, changing course slowly, if at all.

But now it is trying to be more like a speedboat. Since the pandemic, with costs up and ticket sales down, the Met’s programming has taken a sharp swerve toward contemporary works, which used to come along once in a blue moon. In recent seasons, the Met has done fewer productions than it used to, but about a third of its operas now come from our times.

Peter Gelb, the company’s general manager, has staked a large part of his legacy on the bet that these new operas will attract new and more diverse audiences, revitalizing a house repertory better known for presenting “Tosca” and “La Traviata,” year after year. With the Met entering its summer break this week, is that bet paying off, artistically and financially?

The experiment is, at best, a work in progress.

The Met put on 18 operas during this so-so season, and if you line them up in order of paid attendance, only one of the six contemporary pieces, Anthony Davis’s “X: The Life and Times of Malcolm X,” is in the top half. Modern opera is not selling well, at least not better than classics like “The Magic Flute,” “Carmen” and “Turandot.”

The Met’s economic model revolves around being able to efficiently bring back most pieces and have them find an audience. But this season raised alarms about how newer titles will do when revived. Gelb’s gamble on swiftly restaging two top sellers of recent seasons — Terence Blanchard’s “Fire Shut Up in My Bones” and Kevin Puts’s “The Hours” — fizzled, with the theater over a third empty for both. (The average performance across the season was 72 percent full.)